Clinical Trials Directory

Trials / Conditions / Stage IIIB Gastric Cancer

Stage IIIB Gastric Cancer

19 registered clinical trials studyying Stage IIIB Gastric Cancer.

StatusTrialSponsorPhase
UnknownA Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tum
NCT05856500
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolN/A
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
WithdrawnTalazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery an
NCT02567396
National Cancer Institute (NCI)Phase 1
CompletedElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P
NCT02511821
City of Hope Medical CenterN/A
WithdrawnC-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced
NCT02344810
Eastern Cooperative Oncology GroupPhase 1 / Phase 2
SuspendedGenetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advan
NCT02366819
University of ChicagoPhase 4
CompletedGenetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
NCT02333188
University of ChicagoPhase 1
Completed64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer
NCT01939275
City of Hope Medical CenterN/A
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop
NCT01612546
City of Hope Medical CenterPhase 2
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
CompletedBevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal
NCT01212822
Fox Chase Cancer CenterPhase 2
CompletedPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gast
NCT01178944
Roswell Park Cancer InstitutePhase 2
CompletedIrinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophag
NCT00991952
National Cancer Institute (NCI)Phase 2
CompletedCombination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastr
NCT00982592
National Cancer Institute (NCI)Phase 2
CompletedIrinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroe
NCT00084604
National Cancer Institute (NCI)Phase 2
CompletedPhase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carc
NCT00084617
National Cancer Institute (NCI)Phase 2
TerminatedA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
NCT00064259
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Sto
NCT00061932
National Cancer Institute (NCI)Phase 2